Merkel Cell Carcinoma: Risk Factors, Symptoms & Treatment Options

Introduction

Merkel cell carcinoma (MCC) is a rare but aggressive form of skin cancer that originates in Merkel cells, which are located in the top layer of the skin. These cells are connected to nerve endings responsible for the sense of touch. First described in 1972 by Dr. Cyril Toker, MCC has gained attention due to its rapid growth and tendency to spread to other parts of the body, including lymph nodes and internal organs. Although less common than other skin cancers like melanoma or basal cell carcinoma, MCC is more likely to recur and metastasize.

This article aims to provide a comprehensive understanding of Merkel cell carcinoma, covering its risk factors, symptoms, diagnostic tests, treatment options (both medications and procedures), and steps patients can take at home to manage symptoms. By offering this information, we hope to empower patients to make informed decisions about their care and seek timely medical attention.

Definition of Merkel Cell Carcinoma

Merkel cell carcinoma is a rare and aggressive skin cancer influenced by various risk factors, presenting with specific symptoms, diagnosed through specialized tests, and treated with medications, procedures, and at-home care strategies.

Description of Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is a neuroendocrine carcinoma that arises from Merkel cells in the epidermis, the outermost layer of the skin. These cells are involved in touch sensation and are typically found in areas exposed to sunlight, such as the face, neck, and arms. MCC is characterized by rapid growth and a high potential for spreading (metastasis) to nearby lymph nodes and distant organs like the lungs or liver.

One of the key challenges with MCC is that it often presents as a painless, firm, red, or purple nodule on the skin, which can be mistaken for benign skin conditions. As a result, many patients may not seek immediate medical attention, allowing the cancer to progress. MCC can grow quickly and spread, making early detection and treatment critical for improving outcomes.

According to the American Cancer Society, approximately 3,000 new cases of Merkel cell carcinoma are diagnosed annually in the United States. While this number is small compared to other skin cancers, the incidence of MCC has been rising, particularly among older adults and individuals with weakened immune systems. Studies suggest that the 5-year survival rate for MCC varies depending on the stage at diagnosis, with earlier detection leading to better outcomes.

Risk Factors for Developing Merkel Cell Carcinoma

Lifestyle Risk Factors

Certain lifestyle choices can increase the risk of developing Merkel cell carcinoma. The most significant lifestyle-related risk factor is prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. UV radiation damages the DNA in skin cells, leading to mutations that can cause cancer. People who spend a lot of time outdoors without adequate sun protection, such as sunscreen or protective clothing, are at higher risk.

Additionally, individuals who use indoor tanning devices are at an increased risk of developing MCC. Tanning beds emit concentrated UV light, which can be even more harmful than natural sunlight. Avoiding tanning beds and practicing sun safety are key steps in reducing the risk of MCC.

Medical Risk Factors

Several medical conditions can also increase the likelihood of developing Merkel cell carcinoma. One of the most significant risk factors is having a weakened immune system. This can occur due to conditions such as HIV/AIDS, organ transplantation (which requires immunosuppressive medications), or certain cancers like leukemia or lymphoma. A weakened immune system is less able to detect and destroy abnormal cells, allowing cancer to develop more easily.

Another medical risk factor is a history of other skin cancers. Individuals previously diagnosed with melanoma, basal cell carcinoma, or squamous cell carcinoma are at higher risk of developing MCC. This is partly because these individuals may have had significant UV exposure in the past, a shared risk factor for all skin cancers.

Genetic and Age-Related Risk Factors

Age is one of the strongest risk factors for Merkel cell carcinoma. Most cases of MCC occur in people over the age of 65, with the risk increasing as individuals get older. This is likely due to the cumulative effects of sun exposure over a lifetime and the natural weakening of the immune system with age.

Genetic factors may also play a role in the development of MCC, although they are less well understood. People with a family history of skin cancer, particularly those with genetic conditions affecting the skin, may have an increased risk of developing MCC. However, more research is needed to fully understand the genetic components of this disease.

Clinical Manifestations of Merkel Cell Carcinoma

Painless Lump

Approximately 80% of patients with Merkel cell carcinoma (MCC) present with a painless lump. This lump is typically firm and located on sun-exposed areas of the skin, such as the face, neck, or arms. The lump may be mistaken for a benign cyst or other skin condition because it does not cause discomfort initially. MCC causes this symptom as cancerous cells proliferate in the skin’s Merkel cells, which are involved in touch sensation. As the tumor grows, it may push against surrounding tissues without causing pain, delaying diagnosis. Early detection of a painless lump is crucial, as it can grow rapidly and spread to other parts of the body.

Skin Lesion

Skin lesions are seen in about 90% of MCC cases. These lesions often appear red, blue, or purple and may resemble a bruise or pimple. MCC lesions are caused by the uncontrolled growth of Merkel cells in the skin, leading to abnormal skin changes. These lesions are typically found in areas exposed to sunlight, such as the face, neck, and extremities. They can also appear in areas not exposed to the sun, which is why it is important to monitor any unusual skin changes. The appearance of a skin lesion may be one of the earliest signs of MCC, making it important to seek medical evaluation if a new or changing lesion is noticed.

Rapidly Growing Nodule

In 70% of cases, MCC presents as a rapidly growing nodule. This nodule can increase in size over weeks or months. The rapid growth is due to the aggressive nature of MCC, which tends to proliferate quickly compared to other skin cancers. The nodule may start small but can grow significantly in a short period. Rapid growth is a concerning feature and typically prompts further investigation through diagnostic testing. If you notice a nodule that is growing quickly, especially if it is painless, it is important to seek medical attention immediately.

Redness or Inflammation

Redness or inflammation around the tumor is observed in about 30% of MCC cases. This occurs as the body’s immune system reacts to the presence of cancerous cells. The inflammation may cause the skin around the tumor to appear red and swollen. While redness is a common sign of infection or injury, it can also indicate an underlying malignancy like MCC. Inflammation may also occur as the tumor invades nearby tissues, causing irritation and immune response. If you notice persistent redness or swelling around a skin lesion, it is important to consult a healthcare provider.

Ulceration

Ulceration, or the breakdown of skin over the tumor, occurs in about 20% of MCC cases. As the tumor grows, it can disrupt the skin’s surface, leading to open sores or ulcers. Ulceration is a sign that the tumor is advancing and may indicate more aggressive disease. It can also increase the risk of infection, as the open wound provides a pathway for bacteria to enter the body. If you notice any ulceration, particularly in a rapidly growing nodule, it is important to seek medical care promptly.

Itching

Itching is a less common symptom, occurring in about 10% of MCC cases. Itching may occur as the tumor grows and irritates surrounding skin or nerves. While itching is a common symptom for many benign skin conditions, persistent or unexplained itching in the presence of other symptoms like a growing nodule or skin lesion should be evaluated by a healthcare provider. Itching can be a sign that the tumor is affecting nearby tissues or causing an inflammatory response.

Bleeding

Bleeding from the tumor is seen in about 15% of MCC cases. As the tumor grows, it can disrupt blood vessels in the skin, leading to spontaneous bleeding. This is often a sign of more advanced disease. Bleeding may occur after minor trauma to the area, such as scratching or bumping the tumor, but it can also happen without any apparent cause. If you experience unexplained bleeding from a skin lesion or nodule, it is essential to seek medical evaluation.

Lymphadenopathy

Lymphadenopathy, or swollen lymph nodes, is present in about 30% of MCC patients at the time of diagnosis. MCC can spread to nearby lymph nodes, causing them to enlarge. Lymph nodes are part of the body’s immune system and can become swollen when they are fighting an infection or cancer. In MCC, the presence of lymphadenopathy may indicate that the cancer has spread beyond the primary tumor site. Enlarged lymph nodes are often painless but may feel firm or rubbery to the touch. If you notice swollen lymph nodes, especially in combination with other symptoms, it is important to seek medical care.

Pain

Pain is a relatively uncommon symptom in MCC, occurring in about 10% of cases. When pain does occur, it is usually a sign that the tumor is pressing on nearby nerves or tissues. Pain may also develop if the tumor has spread to other parts of the body, such as the bones or organs. While MCC tumors are typically painless in their early stages, the development of pain can indicate more advanced disease. If you experience pain in conjunction with a skin lesion or nodule, it is important to consult a healthcare provider.

Fatigue

Fatigue is a non-specific symptom that can occur in about 15% of MCC patients, especially in advanced stages of the disease. Fatigue may be caused by the body’s immune response to the cancer, the spread of the disease to other organs, or as a side effect of treatment. Fatigue can be debilitating, affecting your ability to perform daily activities. If you are experiencing persistent fatigue along with other symptoms of MCC, it is important to discuss this with your healthcare provider, as it may indicate that the cancer is affecting your overall health.

Treatment Options for Merkel Cell Carcinoma

Medications for Merkel Cell Carcinoma

Avelumab

Definition: Avelumab is an immunotherapy drug that targets the PD-L1 protein, helping the immune system recognize and attack cancer cells, including those in Merkel cell carcinoma.

How and When It’s Used: Avelumab is typically used for advanced or metastatic Merkel cell carcinoma (MCC). It may be a first-line treatment or used after surgery or radiation. Administered via intravenous (IV) infusion, it is usually given every two weeks.

Expected Outcomes: Avelumab has shown promising results in shrinking tumors and slowing disease progression. Improvement may occur within weeks to months, but responses can vary.

Pembrolizumab

Definition: Pembrolizumab is another immunotherapy drug that blocks the PD-1 protein, enabling the immune system to better fight cancer cells, including those in Merkel cell carcinoma.

How and When It’s Used: Pembrolizumab is often used for advanced MCC, especially when the cancer has spread. It is administered via IV infusion every three weeks and is generally considered when surgery or radiation is insufficient.

Expected Outcomes: Pembrolizumab can lead to significant tumor reduction and prolonged survival in some patients, with responses typically seen within a few months.

Nivolumab

Definition: Nivolumab is an immunotherapy drug that helps the immune system detect and destroy cancer cells by inhibiting the PD-1 protein.

How and When It’s Used: Nivolumab is used in advanced or metastatic MCC, particularly when other treatments have failed. It is administered via IV infusion every two to four weeks, especially when the cancer has spread beyond the skin and local lymph nodes.

Expected Outcomes: Patients treated with Nivolumab may experience tumor shrinkage and longer periods without disease progression, with improvements usually seen within a few months.

Chemotherapy for Merkel Cell Carcinoma

Definition: Chemotherapy uses drugs to kill rapidly dividing cancer cells, including those in Merkel cell carcinoma.

How and When It’s Used: Chemotherapy is often used when MCC has spread to other organs or when surgery and radiation are insufficient. It may involve a combination of drugs, administered orally or via IV, and is typically reserved for advanced cases or when other treatments have failed.

Expected Outcomes: While chemotherapy can shrink tumors and slow disease progression, its effects are often temporary, and the cancer may return.

Radiation Therapy for Merkel Cell Carcinoma

Definition: Radiation therapy uses high-energy rays to target and kill cancer cells in specific areas, including those affected by Merkel cell carcinoma.

How and When It’s Used: Radiation is commonly used after surgery to eliminate remaining cancer cells or as a primary treatment for patients unable to undergo surgery. It may also treat MCC that has spread to lymph nodes or other areas. Sessions are typically scheduled several times a week over a few weeks.

Expected Outcomes: Radiation therapy can reduce the risk of recurrence and shrink tumors, with improvement often seen within weeks of starting treatment.

Surgery for Merkel Cell Carcinoma

Definition: Surgery involves the physical removal of the tumor and surrounding tissue to eliminate cancer cells, including those in Merkel cell carcinoma.

How and When It’s Used: Surgery is often the first-line treatment for localized MCC. The surgeon removes the tumor along with a margin of healthy tissue to ensure all cancer cells are excised. Surgery may be followed by radiation or chemotherapy to reduce the risk of recurrence.

Expected Outcomes: Surgery can be highly effective in removing the primary tumor, especially when caught early. Recovery times vary, but patients can expect to see results within a few weeks.

Other Medications for Merkel Cell Carcinoma

Ipilimumab

Definition: Ipilimumab is an immunotherapy drug that enhances the immune system’s ability to fight cancer by blocking the CTLA-4 protein.

How and When It’s Used: Ipilimumab is typically used in combination with other immunotherapies like Nivolumab for advanced MCC. It is administered via IV infusion and is usually considered when other treatments have not been effective.

Expected Outcomes: Some patients may experience tumor shrinkage and slower disease progression, with responses taking several months to become evident.

Doxorubicin

Definition: Doxorubicin is a chemotherapy drug that interferes with the DNA of cancer cells, preventing them from growing and dividing.

How and When It’s Used: Doxorubicin is used in aggressive or advanced MCC cases, particularly when other treatments have failed. It is administered via IV infusion, often as part of a combination chemotherapy regimen.

Expected Outcomes: Doxorubicin can shrink tumors and slow the spread of cancer, though its effects may be temporary.

Carboplatin

Definition: Carboplatin is a chemotherapy drug that damages the DNA of cancer cells, preventing them from multiplying.

How and When It’s Used: Carboplatin is often used in combination with other chemotherapy drugs for advanced MCC. It is administered via IV infusion and is typically reserved for cases where the cancer has spread beyond the skin.

Expected Outcomes: Carboplatin can reduce tumor size and slow disease progression, though its effects may not be long-lasting.

Taxanes

Definition: Taxanes are a class of chemotherapy drugs that prevent cancer cells from dividing and growing.

How and When It’s Used: Taxanes, such as paclitaxel or docetaxel, are used in advanced MCC cases, often in combination with other chemotherapy agents. They are administered via IV infusion and are typically considered when other treatments have not been successful.

Expected Outcomes: Taxanes can slow cancer growth and reduce tumor size, but their effects may be temporary.

Procedures for Merkel Cell Carcinoma

Wide Local Excision

Definition: Wide local excision is a surgical procedure that removes the tumor along with a margin of healthy tissue to ensure all cancer cells are eliminated.

How and When It’s Used: This procedure is typically the first treatment for localized MCC. It is performed under local or general anesthesia, depending on the size and location of the tumor.

Expected Outcomes: Wide local excision can be highly effective in removing the primary tumor, especially when combined with other treatments like radiation.

Sentinel Lymph Node Biopsy

Definition: A sentinel lymph node biopsy is a procedure that identifies and removes the first lymph node(s) to which cancer cells are likely to spread.

How and When It’s Used: This procedure is often performed during surgery to remove the primary tumor. It helps determine whether the cancer has spread to the lymph nodes and guides further treatment decisions.

Expected Outcomes: A sentinel lymph node biopsy provides important information about the cancer stage and whether additional treatments like radiation or chemotherapy are needed.

Lymphadenectomy

Definition: Lymphadenectomy is a surgical procedure that removes lymph nodes affected by cancer.

How and When It’s Used: This procedure is typically performed when MCC has spread to the lymph nodes. It is often done in conjunction with other treatments like radiation or chemotherapy.

Expected Outcomes: Lymphadenectomy can help prevent cancer spread and improve long-term survival rates, though recovery may take several weeks.

Improving Merkel Cell Carcinoma Outcomes and Seeking Medical Help

While medical treatments are essential for managing Merkel cell carcinoma, several lifestyle changes and home remedies can support your overall health and improve outcomes:

1. Maintain a healthy diet: A balanced diet rich in fruits, vegetables, and lean proteins supports your immune system and overall well-being.
2. Regular exercise: Staying active can boost energy levels, reduce stress, and enhance mood.
3. Stress management: Practices like meditation, yoga, and deep breathing can help reduce stress, improving your ability to cope with cancer treatment.
4. Adequate sleep: Getting enough rest is crucial for healing and recovery from treatments.
5. Sun protection: Protect your skin from UV rays by wearing sunscreen and protective clothing to prevent further skin damage.
6. Avoid tobacco: Smoking impairs your immune system and increases the risk of complications.
7. Limit alcohol consumption: Reducing alcohol intake supports overall health and treatment outcomes.
8. Stay hydrated: Drinking plenty of water helps your body function properly and supports recovery.
9. Regular medical check-ups: Follow-up appointments allow your healthcare team to monitor progress and adjust treatments as needed.
10. Support groups: Joining a support group provides emotional support and practical advice from others going through similar experiences.

Telemedicine offers a convenient way to stay in touch with your healthcare team and manage your condition from home. If you notice new or worsening symptoms, such as skin changes or unexplained pain, seek medical help promptly. Telemedicine allows you to consult with your doctor quickly, ensuring concerns are addressed without delay.

Living with Merkel Cell Carcinoma: Tips for Better Quality of Life

Living with Merkel cell carcinoma can be challenging, but there are ways to improve your quality of life:

1. Stay informed about your condition and treatment options to make empowered decisions about your care.
2. Maintain a strong support system of family, friends, and healthcare providers.
3. Practice self-care by eating well, exercising, and managing stress.
4. Communicate openly with your healthcare team about any side effects or concerns during treatment.
5. Consider joining a support group to connect with others who understand what you’re going through.

Conclusion

Merkel cell carcinoma is a rare but aggressive form of skin cancer that requires prompt diagnosis and treatment. Early intervention with treatments like surgery, immunotherapy, and radiation can significantly improve outcomes. By staying vigilant and seeking medical help early, you can increase your chances of successful treatment.

Our telemedicine practice is here to provide accessible and compassionate care, guiding you through every step of your journey with Merkel cell carcinoma. If you have concerns or need to discuss treatment options, don’t hesitate to schedule a virtual consultation with one of our primary care providers.

James Kingsley

Learn More